Description
The marker is associated with the peculiarities of absorption of certain drugs in the intestine. It is investigated to detect the physiological effectiveness of the use of drugs of the following groups: antiplatelet agents (clopidogrel and its analogs), psychotropic, antiepileptic (carbamazepine, phenytoin, olanzapine), drugs for the treatment of HIV infection (lamivudine, lopinavir, ritonavir, zidovudine, vincristine, oxaliplatin), drugs for the treatment of cardiovascular diseases (atorvastatin, simvastatin, losartan), analgesics (morphine, nortriptyline, fentanyl, tramadol, oxycodone), antitumor (methotrexate, tamoxifen, bleomycin, etoposide), targeted (imatinib), etc.
Period of execution
Within 7 days. The specified time does not include the day of biomaterial collection
Biomaterial type
- Buccal (cheek) epithelium
- Venous blood